NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global beta lactam and beta lactamase inhibitors market size is estimated to grow by USD 8.4 billion from ...
The Global Beta-lactam and Beta-lactamase Inhibitors Market study includes a rounded approach for the market by analysing past data and analysis uncovered from the leading vendors. Overall, the ...
The Beta-lactam and Beta-lactamase Inhibitors Market encompasses a wide range of antibiotics and enzyme inhibitors used in the treatment of various bacterial infections. Beta-lactams are a class of ...
Pune, Maharashtra, India, December 17 2020 (Wiredrelease) Allied Analytics –:Increase in demand for antimicrobial resistance medication play a major role in the growth of the beta-lactam and ...
Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Astellas Pharma Inc., Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lupin Ltd., Meiji ...
Abbott Laboratories, AbbVie Inc., Alkem Laboratories Ltd., Astellas Pharma Inc., Cipla Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Lupin Ltd., Meiji ...
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global beta lactam and beta lactamase inhibitors market size is estimated to grow by USD 8.4 billion from ...
Beta lactam and beta lactamase inhibitors are a class of antibacterial agents used to treat various bacterial infections. These agents work by inhibiting the action of beta-lactamases, enzymes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback